Chin. J. Org. Chem. ›› 2019, Vol. 39 ›› Issue (7): 1953-1961.DOI: 10.6023/cjoc201812037 Previous Articles     Next Articles



高粟繁a,b, 张艳春a,b, 李家明a,b, 张斌a,b, 杨雨a,b, 胡孟奇a,b   

  1. a 安徽中医药大学药学院 合肥 230012;
    b 安徽省中医药科学院药物化学研究所 合肥 230012
  • 收稿日期:2018-12-19 修回日期:2019-02-02 发布日期:2019-04-08
  • 通讯作者: 李家明
  • 基金资助:


Synthesis and Biological Evaluation of Novel Phenylpropenoyl-amino Acid Derivatives

Gao Sufana,b, Zhang Yanchuna,b, Li Jiaminga,b, Zhang Bina,b, Yang Yua,b, Hu Mengqia,b   

  1. a College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012;
    b Deparment of Medicinal Chemistry, Anhui Academy of Chinese Medicine, Hefei 230012
  • Received:2018-12-19 Revised:2019-02-02 Published:2019-04-08
  • Contact: 10.6023/cjoc201812037
  • Supported by:

    Project supported by the National Science and Technology Major Project in 12th Five-Year (No. 2012ZX09401-006).

Based on the listed drug rebamipide, a series of novel compounds of phenylpropenoyl-amino acid structures were designed and synthesized according to the pharmacophore-combination strategy. The structures of the target compounds were confirmed by NMR and MS. The inhibitory activities against IL-6 and TNF-α had been investigated. The results demonstrated that all compounds exhibited moderate IL-6 and TNF-α inhibitory activities. In particular, the activities of four compounds were significantly improved than that of rebamipide.

Key words: IL-6, TNF-α, phenylpropenoyl-amino acid, synthesis